NDRA · ENDRA Life Sciences Inc.
$4.60
+0.03 (+0.55%)
At close · Aug 7
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has not established an ongoing source of revenue sufficient to cover its operating costs and to allow it to continue as a going concern and will require additional financing to fund its future planned operations, including research and development and commercialization of its products. These matters raise substantial doubt about the Company's ability to continue as going concern.”View the 10-Q filed May 15, 2026
Market Cap
$5.84M
Shares
1.27M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding NDRA
3 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | — | 14,580 | $80,190 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,816 | $13,094 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 1,597 | $8,784 | 0.00% | Long | 2026-05-31 |
Showing 1–3 of 3 positions